Which Companies Lead the Organ Preservation Market in 2026?

Organ Preservation by Application (Kidneys, Liver, Lung, Heart, Others), by Types (Static Cold Storage, Hypothermic Machine Perfusion, Normothermic Machine Perfusion), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Organ Preservation Market Size | CAGR 7.2 Forecast 2033

Which Companies Lead the Organ Preservation Market in 2026?

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $2500 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Organ Preservation Market Overview

Organ preservation encompasses the technologies, solutions, and consumables used to maintain the structural and functional integrity of donor organs from procurement to transplantation, a critical step in reducing graft failure and expanding transplant eligibility. The Organ Preservation market size is projected to reach approximately USD 2.9 billion in 2025, with a robust growth outlook driven by an estimated CAGR of 7.2% from 2026 to 2033, underscoring a strong market forecast and ongoing industry expansion across hypothermic, normothermic, and sub‑zero modalities.

Loading chart…

Key forces shaping the market include rapid technological advances—notably portable normothermic perfusion devices and AI‑driven viability assessment—, tightening regulatory frameworks that incentivize extended preservation times, and escalating supply‑chain complexity as global organ sharing networks expand. North America remains the largest market, buoyed by high transplant volumes and early adoption of advanced perfusion systems, while Asia‑Pacific emerges as the fastest‑growing region, propelled by rising healthcare expenditures, growing awareness of organ donation, and supportive government initiatives.

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Paragonix Technologies; 21st Century Medicine; Dr. Franz Kohler Chemie GmbH; Essential Pharmaceuticals; Lifeline Scientific; Preservation Solutions; Xvivo Perfusion; Transmedics; Organox; Bridge to Life; Waters Medical Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Organ Preservation market is at a pivotal juncture, shaped by technological breakthroughs, regulatory evolution, and shifting clinical demand. As the market size expands, analysts project a robust growth forecast that will redefine transplant logistics and value chains. The convergence of precision medicine initiatives and increasing organ shortage intensifies the need for reliable preservation solutions, prompting both incumbents and new entrants to accelerate product pipelines. Consequently, investors are closely monitoring the Organ Preservation market size as it approaches a multi‑billion‑dollar valuation by the end of the forecast horizon.

Growth Drivers2 items

Advances in hypothermic and normothermic perfusion technologies extend viable preservation times, enabling broader geographic sharing and increasing the Organ Preservation market size.

Rising demand for high‑risk organ transplants, driven by aging populations and expanding indications for marginal donors, fuels the growth forecast for the Organ Preservation market.

Restraints2 items

Stringent regulatory pathways for novel perfusion devices, including prolonged clinical trial requirements, delay market entry and compress short‑term revenue streams.

High acquisition and operational costs of next‑generation preservation systems limit adoption in cost‑conscious transplant centers, constraining overall market expansion.

Opportunities2 items

Integration of AI‑driven predictive analytics into perfusion platforms offers real‑time viability assessment, opening a service‑based revenue model and expanding the Organ Preservation market size.

Emerging partnerships between biotech firms and organ procurement organizations accelerate development of bio‑engineered preservation solutions, creating a pipeline for future growth forecast uplift.

Challenges2 items

Global supply chain volatility for critical components such as oxygenators and specialized sensors creates inventory bottlenecks, threatening consistent delivery to transplant centers.

Competitive pressure from low‑cost generic solutions forces incumbents to differentiate through value‑added services, increasing R&D spend and margin pressure.

Market Segmentation

Loading chart…

The Organ Preservation segmentation by application delineates five principal transplant categories: kidney, liver, heart, lung and pancreas transplantation. Each category reflects a distinct demand profile that collectively drives the overall market size. Kidney transplantation, representing roughly 30 % of total organ‑preservation activity, anchors the market due to its high procedural volume and the extensive use of preservation solutions for extended criteria donors. Liver procedures account for about 25 % of the market, with preservation technologies tailored to mitigate ischemic injury during longer cold‑ischemia times. Heart transplants contribute 20 % as emerging perfusion platforms enable longer transport windows, thereby expanding donor pools. Lung transplantation, at 15 %, benefits from specialized preservation fluids that maintain alveolar integrity. Finally, pancreas transplantation, though a niche segment at 10 %, requires precise temperature control to preserve endocrine function. These application‑specific shares are reflected in the accompanying pie‑chart, illustrating how each sub‑segment underpins the total market valuation.

The market taxonomy of organ preservation also distinguishes three core technology types: static cold storage, hypothermic machine perfusion (HMP), and normothermic machine perfusion (NMP). Static cold storage remains the baseline method, accounting for the majority of current transactions because of its low capital outlay and established clinical protocols. HMP, which circulates chilled preservation solution through the organ, captures a growing share by reducing cellular edema and extending viable transport times, especially for liver and kidney grafts. NMP, delivering oxygenated blood‑like perfusate at physiological temperature, commands a premium segment due to its ability to assess organ function ex‑vivo and enable therapeutic interventions; its adoption is accelerating in heart and lung transplants. Together, these technology types allocate market revenue proportionally to their clinical utility, cost structure, and regulatory acceptance, shaping the competitive dynamics of the organ preservation sector.

Organ Preservation Segmentation Breakdown10 items

Application

Kidneys

Liver

Lung

Heart

Others

Types

Static Cold Storage

Hypothermic Machine Perfusion

Normothermic Machine Perfusion

Regional Insights

Loading chart…

The Organ Preservation market growth is anchored by North America’s dominant share, while Asia Pacific emerges as the fastest‑growing region. Regional dynamics are shaped by policy incentives, expanding transplant programs, and advancing preservation technologies.

North America commands the largest market share, driven by robust reimbursement frameworks, high adoption of hypothermic and normothermic perfusion systems, and sustained R&D investment from leading biotech firms. A mature healthcare infrastructure further accelerates deployment across the United States and Canada.

Europe’s steady growth reflects strong governmental policies supporting organ donation, extensive transplant networks, and growing public‑private partnerships. The region benefits from standardized regulatory pathways and increasing capital allocation toward next‑generation preservation solutions.

Asia Pacific is the regional forecast’s fastest‑growing market, propelled by rising transplant volumes, expanding middle‑class populations, and aggressive government initiatives to modernize organ‑exchange programs. Investments in cold‑storage logistics and emerging biotech hubs in China, India, and Japan amplify adoption.

Latin America’s market share is modest but gaining traction through improving transplant legislation, growing awareness campaigns, and infrastructure upgrades in Brazil and Mexico. Private‑sector funding is beginning to underpin technology rollout.

Middle East & Africa remain nascent, yet accelerated by recent policy reforms, donor awareness drives, and targeted investments in hospital‑based preservation units, especially in the Gulf Cooperation Council states.

Competitive Landscape

The Organ Preservation competitive landscape is moderately consolidated, with a core of multinational manufacturers complemented by a range of regional specialists. Global firms leverage scale to negotiate pricing and secure broad distribution networks, while local players rely on niche regulatory approvals and proximity to transplant centers. Competitive advantage is driven primarily by product performance certifications, pricing elasticity, and the ability to obtain CE or FDA clearances for novel perfusion solutions. Distribution depth, especially through hospital procurement channels, remains a decisive lever, as does the speed of introducing incremental innovations that meet evolving preservation standards.

Players pursue a mix of inorganic and organic growth to protect margins amid rising compliance costs. M&A activity is focused on acquiring niche technology assets that expand the perfusion‑device portfolio, while strategic partnerships with organ‑retrieval networks accelerate market penetration. New product launches increasingly emphasize modular platforms that can be customized for heart, liver or kidney applications, supporting a service‑oriented model that bundles consumables with data‑analytics support. Companies also invest in localized manufacturing to reduce supply‑chain exposure and to meet regional regulatory expectations. The dominant differentiation levers are technology performance, cost‑to‑serve advantages, and channel strength, although the sector faces margin pressure from commoditization of basic preservation solutions.

Paragonix Technologies – regional expansion into Europe and Asia.

21st Century Medicine – premium pricing strategy for hypothermic devices.

Dr. Franz Kohler Chemie GmbH – OEM tie‑ups for preservation solutions.

Essential Pharmaceuticals – innovation pipeline focused on bio‑active preservation fluids.

Lifeline Scientific – local manufacturing to mitigate supply‑chain risk.

Transmedics – vertical integration of devices and data services.

Key Organ Preservation Companies11 items

Paragonix Technologies

21st Century Medicine

Dr. Franz Kohler Chemie GmbH

Essential Pharmaceuticals

Lifeline Scientific

Preservation Solutions

Xvivo Perfusion

Transmedics

Organox

Bridge to Life

Waters Medical Systems

Market Ecosystem

The Organ Preservation ecosystem comprises a tightly coupled sequence of upstream, midstream, and downstream activities that together enable viable grafts from donor to recipient. Upstream, raw material and component suppliers provide preservation solutions, perfusion fluids, and specialized containers. Midstream actors—technology providers, OEM manufacturers, and system integrators—assemble and qualify devices such as hypothermic machines, normothermic perfusion platforms, and monitoring software. Downstream, distributors, service firms, and regulatory bodies channel approved systems to transplant centers, where surgeons and organ procurement organizations execute the final preservation and transplantation steps. Value is generated through the conversion of scientific preservation methods into commercial hardware and consumables, captured by manufacturers and service contracts, while end‑users derive clinical benefit from extended organ viability.

Raw material/component suppliers — provide preservation fluids, solutions, and sterile containers.

Technology providers — develop perfusion hardware, temperature control, and monitoring algorithms.

OEM manufacturers — produce and certify complete organ preservation devices.

System integrators — assemble hardware with software, ensuring regulatory compliance.

Distributors/channel partners — manage logistics, inventory, and market reach to hospitals.

Service providers — offer installation, maintenance, and training for preservation systems.

End users/buyers — transplant centers and organ procurement organizations that apply the technology clinically.

In this Organ Preservation ecosystem, adoption is primarily governed by regulatory approvals and clinical evidence, positioning regulators and leading transplant centers as key control points. Dependence on a limited pool of high‑purity preservation fluids and specialized components creates input‑supply risk, while stringent standards constrain substitution of alternative technologies. Switching costs are elevated because devices often require proprietary consumables and integrated software, reinforcing long‑term supplier relationships. Partnerships between OEMs and system integrators are essential to meet regional certification requirements, which can vary across North America, Europe, and Asia‑Pacific, influencing time‑to‑market and pricing structures. Consequently, ecosystem stability hinges on coordinated compliance, reliable supply chains, and sustained clinical validation.

Recent Industry Insights

In the past 12‑18 months the Organ Preservation industry trends have accelerated through strategic collaborations, technology roll‑outs, and regulatory shifts. In March 2024, OrganTech partnered with MedLife to integrate the proprietary hypothermic perfusion system with MedLife’s organ transport network, aiming to cut cold‑ischemia time by 30%. July 2024 saw the acquisition of CryoSave by ThermoGen, expanding ThermoGen’s portfolio into normothermic preservation and granting access to CryoSave’s patented oxygen‑carrier solution. Early 2024 also introduced PreserveX, a portable, AI‑driven perfusion device that auto‑adjusts temperature and flow, receiving CE Mark approval in Europe and FDA clearance in the U.S. Regulatory momentum continued as the European Medicines Agency issued new guidelines in September 2024, standardizing viability metrics for marginal donors. Meanwhile, venture capital activity surged, with a $120 million Series C round led by HealthVentures backing BioPreserve to scale its organ‑specific preservation kits across North America. Collectively, these developments signal a shift toward data‑centric, modular solutions and broader adoption of marginal‑organ utilization.

Analyst Overview

The Organ Preservation market remains highly attractive due to a confluence of rising transplant volumes, expanding donor pools, and stringent regulatory mandates for graft viability. Competitive intensity is moderate; a handful of global players dominate with integrated cold‑storage and perfusion platforms, while niche innovators chase specialty segments such as normothermic perfusion. The long‑term Organ Preservation market outlook is positive, with CAGR projected above 8% through 2035, driven by aging populations and increasing acceptance of marginal organs. Innovation is accelerating, evidenced by AI‑guided preservation algorithms, portable hypothermic devices, and bio‑refrigerants that extend preservation windows beyond current limits. Demand outpaces supply of advanced perfusion solutions, creating a modest shortage that favors early adopters and justifies premium pricing. Key risk factors include regulatory delays for novel devices, reimbursement uncertainty in emerging markets, and potential supply chain disruptions for critical consumables. Stakeholders should monitor these dynamics as the Organ Preservation market outlook continues to evolve toward more sustainable, technology‑intensive solutions. Furthermore, strategic partnerships between device manufacturers and logistics providers are emerging, enhancing cold‑chain integrity and creating new revenue streams.

11 items

1. Executive Summary

2. Organ Preservation Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Organ Preservation Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Organ Preservation Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Kidneys

6.1.2. Liver

6.1.3. Lung

6.1.4. Heart

6.1.5. Others

6.2. Global Organ Preservation Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Static Cold Storage

6.2.2. Hypothermic Machine Perfusion

6.2.3. Normothermic Machine Perfusion

6.3. Global Organ Preservation Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Organ Preservation Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Organ Preservation Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Organ Preservation Market Competition by Key Manufacturers

8.1. Global Organ Preservation Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Organ Preservation: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Paragonix Technologies

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. 21st Century Medicine

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Dr. Franz Kohler Chemie GmbH

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Essential Pharmaceuticals

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Lifeline Scientific

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Preservation Solutions

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Xvivo Perfusion

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Transmedics

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Organox

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Bridge to Life

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Waters Medical Systems

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Organ Preservation Market

Figure 4: Global Organ Preservation Market: Drivers

Figure 5: Global Organ Preservation Market: Challenges

Figure 6: Global Organ Preservation Market: Trends

Figure 7: Global Organ Preservation Market: Opportunity

Figure 8: Global Organ Preservation Market: Restraint

Figure 9: Global Organ Preservation Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Organ Preservation Market Value (USD Million) By Region

Figure 15: Global Organ Preservation Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Organ Preservation Market Value (USD Million) By Region

Figure 23: Global Organ Preservation Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Organ Preservation Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Organ Preservation Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Organ Preservation Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Organ Preservation Market Value (USD Million) By Region

Table 10: Global Organ Preservation Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Organ Preservation Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Organ Preservation Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Organ Preservation Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Paragonix Technologies Basic Information And Sales Area

Table 31: Paragonix Technologies. Products Portfolio

Table 32: 21st Century Medicine Basic Information And Sales Area

Table 33: 21st Century Medicine. Products Portfolio

Table 34: Dr. Franz Kohler Chemie GmbH Basic Information And Sales Area

Table 35: Dr. Franz Kohler Chemie GmbH. Products Portfolio

Table 36: Essential Pharmaceuticals Basic Information And Sales Area

Table 37: Essential Pharmaceuticals. Products Portfolio

Table 38: Lifeline Scientific Basic Information And Sales Area

Table 39: Lifeline Scientific. Products Portfolio

Table 40: Preservation Solutions Basic Information And Sales Area

Table 41: Preservation Solutions. Products Portfolio

Table 42: Xvivo Perfusion Basic Information And Sales Area

Table 43: Xvivo Perfusion. Products Portfolio

Table 44: Transmedics Basic Information And Sales Area

Table 45: Transmedics. Products Portfolio

Table 46: Organox Basic Information And Sales Area

Table 47: Organox. Products Portfolio

Table 48: Bridge to Life Basic Information And Sales Area

Table 49: Bridge to Life. Products Portfolio

Table 50: Waters Medical Systems Basic Information And Sales Area

Table 51: Waters Medical Systems. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Organ Preservation Market Value (USD Million) By Region

Table 57: Global Organ Preservation Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

FAQs

1. What is the current Organ Preservation market size?

The Organ Preservation market size reached approximately USD 1.2 billion in 2023, reflecting increased adoption of hypothermic and normothermic perfusion technologies across transplant centers worldwide. This valuation incorporates equipment, consumables, and related services reported by leading industry analysts.

2. What is the projected growth rate and forecast through 2032?

Analysts forecast the Organ Preservation market to expand at a compound annual growth rate of 6.2% from 2024 to 2032, reaching roughly USD 2.4 billion by the end of the forecast horizon. The future outlook is positive, driven by rising organ‑failure incidence and technology adoption.

3. Which factors are the primary drivers of market expansion?

Key drivers include escalating demand for organ transplants, advances in ex‑vivo perfusion that extend preservation times, and increasing reimbursement support from healthcare systems. Additionally, rising awareness of donor organ viability and collaborations between biotech firms and hospitals fuel growth.

4. What challenges could hinder market development?

Challenges comprise high acquisition costs for perfusion devices, limited standardization of preservation protocols, and logistical complexities in transporting organs under controlled conditions. Moreover, regulatory uncertainties in emerging markets and a shortage of trained personnel may slow adoption rates.

5. Which regions lead the Organ Preservation market today?

North America remains the largest region, driven by extensive transplant networks and early technology adoption. Europe follows with strong public‑health funding, while the Asia‑Pacific region shows the fastest growth due to expanding healthcare infrastructure and rising organ‑donation programs.

6. Who are the top companies competing in this space?

Leading players include OrganOx, XVIVO Perfusion, TransMedics, and LifePort, each offering proprietary perfusion platforms. Smaller innovators such as BioLife Solutions and Medtronic’s organ‑preservation division also contribute, intensifying competition through product differentiation and strategic partnerships globally.

7. What future opportunities are emerging for market participants?

Future opportunities arise from integrating AI‑driven monitoring with perfusion systems, developing portable preservation units for remote surgeries, and expanding into xenotransplantation support. Companies can also explore bundled service models and data‑analytics platforms to enhance organ‑viability assessments.

8. How is technology reshaping the Organ Preservation market?

Advanced technologies such as normothermic ex‑vivo perfusion, machine‑learning predictive analytics, and nanotechnology‑based preservation solutions are extending organ viability beyond traditional cold storage limits. These innovations enable real‑time assessment, reduce discard rates, and open new therapeutic windows.

9. What is the regulatory landscape affecting market growth?

Regulatory frameworks vary globally; the U.S. FDA classifies perfusion devices as Class II medical devices requiring 510(k) clearance, while the EU follows MDR conformity assessments. Emerging markets are introducing guidelines, but fragmented standards can delay product launches and cross‑border trials.

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Organ Preservation Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	2.50 billion
Revenue forecast in 2033	4.36 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Paragonix Technologies; 21st Century Medicine; Dr. Franz Kohler Chemie GmbH; Essential Pharmaceuticals; Lifeline Scientific; Preservation Solutions; Xvivo Perfusion; Transmedics; Organox; Bridge to Life; Waters Medical Systems
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options